NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Arvinas, Inc Share Price Chart

O H L

Arvinas, Inc Performance Overview

Days Range
$8.23Low
$8.28High

Markets Today

Previous Close$8.31
Open$8.28
Volume79,807
Day's Range$8.23 - $8.28
52W Range$6.97 - $14.51
Market Cap$533.55 M

Historical Performance

1M Returns-10.26
3M Returns+8.34
6M Returns-23.69
1Y Returns+7.64
5Y Returns-91.39
10Y ReturnsNA

Arvinas, Inc Fundamentals

Market Cap$533.55 M
Dividend yield0.00
PE Ratio50.89
PEG RatioN/A
Revenue$262.60 M
ROE TTM-0.16
EPS TTM$0.16
Quarterly Earnings Growth YOYN/A
PB Ratio0.95
EBITDA$-111.20 M
Profit Margin-30.77
Market Cap$533.55 M
Dividend yield0.00
PE Ratio50.89
PEG RatioN/A
Revenue$262.60 M
ROE TTM-0.16
EPS TTM$0.16
Quarterly Earnings Growth YOYN/A
PB Ratio0.95
EBITDA$-111.20 M
Profit Margin-30.77

Arvinas, Inc Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$188.80 M$22.40 M$41.90 M$9.50 M$15.60 M$249.70 M
Gross Profit +$188.80 M$22.40 M$41.90 M$9.50 M$15.60 M$240.70 M
Operating Income $71.40 M-$71.50 M-$43.80 M-$74.60 M-$63.80 M$164.10 M
EBITDA $75.40 M-$74.00 M-$43.00 M-$69.60 M-$62.80 M$164.50 M
Interest Expense $0$0$0$0$0$0
Depreciation $4.00 M-$2.50 M$800.00 K$5.00 M$1.00 M$400.00 K
Income Before Tax $83.10 M-$61.50 M-$34.80 M-$67.20 M-$57.50 M$169.60 M
Income Tax Expense $200.00 K-$300.00 K$300.00 K$200.00 K$100.00 K$200.00 K
Net Income +$82.90 M-$61.20 M-$35.10 M-$67.40 M-$57.60 M$169.40 M
Net Profit Margin 43.91%-273.21%-83.77%-709.47%-369.23%67.84%

Arvinas, Inc Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $100.00 K$100.00 K$100.00 K$100.00 K$100.00 K$100.00 K
Reserve & Surplus -$1.45 B-$1.51 B-$1.54 B-$1.61 B-$1.67 B-$1.50 B
Non-Current Liabilities $127.00 M$142.20 M$135.00 M$141.50 M$144.80 M$30.40 M
Current Liabilities $214.00 M$157.80 M$144.90 M$142.50 M$115.90 M$82.50 M
Total Liabilities $341.00 M$300.00 M$279.90 M$284.00 M$260.70 M$112.90 M
Fixed Assets $6.70 M$6.10 M$5.40 M$5.20 M$5.50 M$5.00 M
Current Assets $979.70 M$889.50 M$826.30 M$700.70 M$630.70 M$652.20 M
Total Assets $1.00 B$909.30 M$844.30 M$717.90 M$647.50 M$675.10 M

Arvinas, Inc Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income $82.90 M-$61.20 M-$35.10 M-$67.40 M-$57.60 M$169.40 M
Operating Cash Flow -$88.90 M-$95.40 M-$59.10 M-$30.40 M-$69.20 M-$48.30 M
Investing Cash Flow $69.50 M$128.80 M$63.50 M$145.80 M$13.70 M$54.90 M
Financing Cash Flow -$100.00 K$500.00 K-$17.80 M-$74.00 M-$100.00 K$400.00 K
Change in Cash -$19.50 M$33.90 M-$13.40 M$41.40 M-$55.60 M$7.00 M

Arvinas, Inc Return Calculator

The Arvinas, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$856
Invested Amount$10,000
Est. Returns$-9,144
Invest in USA Stock Today

About Arvinas, Inc

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

FAQs

Arvinas, Inc (ARVN) share price as of September 18, 2026 is $8.26. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Arvinas, Inc (ARVN) Share by opening an international trading account with Angel One.
Purchasing Arvinas, Inc (ARVN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Arvinas, Inc (ARVN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Arvinas, Inc (ARVN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Arvinas, Inc on September 18, 2026, is $533.55 M.
Arvinas, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Arvinas, Inc (ARVN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91